Results 31 to 40 of about 245 (84)

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA

Рациональная фармакотерапия в кардиологии, 2015
The clinical significance of the patient genetic characteristics in the individual pharmacological response to oral anticoagulants is considered. Possible tactics of warfarin dosing and new oral anticoagulants choice on the basis of pharmacogenetic ...
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev   +3 more
doaj   +1 more source

Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events

Рациональная фармакотерапия в кардиологии, 2015
Aim. Pharmacoeconomic analysis of apixaban use compared to conventional therapy in patients with venous thromboembolism (VTE).Material and methods. Economic evaluation was performed from a position of the health care system.
O. V. Shatalova
doaj   +1 more source

Новые оральные антикоагулянты для лечения и вторичной профилактики тромбоза глубоких вен нижних конечностей и тромбоэмболии легочной артерии: первый опыт и результаты применения дабигатрана [PDF]

, 2015
АНТИКОАГУЛЯНТЫ /ТЕР ПРИМВВЕДЕНИЕ ЛЕКАРСТВ ПЕРОРАЛЬНОЕТРОМБОЗ ВЕНОЗНЫЙ /ЛЕК ТЕР /ПРОФКОНЕЧНОСТЬ НИЖНЯЯТРОМБОЭМБОЛИЯЛЕГОЧНАЯ ЭМБОЛИЯЛЕГОЧНАЯ ...
Карбышев, И. А., Петриков, А. С., Захарченко, К. К., Шойхет, Я. Н., Вяткин, Д. А.   +4 more
core  

THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY

Рациональная фармакотерапия в кардиологии, 2015
On the basis of the analysis of published data the role of P-glycoprotein, carrier protein, in rational pharmacotherapy in cardiology was shown on the example of its substrates – digoxin, antiplatelet agents and anticoagulants.
A. V. Shulkin, E. N. Yakusheva, N. M. Popova   +2 more
doaj   +1 more source

Study of pharmacotherapy in patients with atrial fibrillation [PDF]

, 2020
The article deals the features of pharmacotherapy in patients with atrial fibrillation in one of the cardiac centers. It is revealed that in real practice, oral anticoagulants are not often prescribed in patients with atrial fibrillation.В статье ...
Pavlova, V. N., Павлова, В. Н.
core  

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION

Рациональная фармакотерапия в кардиологии, 2015
Prevention of thromboembolic complications in patients with atrial fibrillation during catheter pulmonary veins isolation is discussed. This subject review is presented with special consideration to new anticoagulants.
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva   +2 more
doaj   +1 more source

Особенности течения и лечебная тактика абдоминального синдрома геморрагического васкулита у детей [PDF]

, 2015
геморрагический васкулит, терапия, антикоагулянты,антиагрегантная терапия ...
Лашковская, Т. А., Гузаревич, В. Б.   +1 more
core  

PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT

Рациональная фармакотерапия в кардиологии, 2015
Venous thromboembolic (VTE) events are a major concern in large joints replacement leading to patients’ death. The prevention of VTE events suggests the prescription of low molecular weight heparin or oral anticoagulants that differ significantly in ...
A. V. Rudakova
doaj   +1 more source

ВАРФАРИН: МЕСТО В СОВРЕМЕННОЙ АНТИКОАГУЛЯНТНОЙ ТЕРАПИИ

, 2016
A trial fibrillation is the most common cardiac source of systemic emboli and car-a significant reduction or even blockage of dioembolic stroke. Anticoagulants are recommended for preventing  stroke in patients with non-valvular  atrial fibrillation ...
A. N. Volovchenko, А. Н. Воловченко, Н. А. Новикова, N. A. Novikova   +3 more
core   +1 more source

Оценка эффективности антикоагулянтной терапии методом тромбодинамики [PDF]

, 2015
АНТИКОАГУЛЯНТЫ /ТЕР ПРИМТРОМБОЗ ВЕНОЗНЫЙКОНЕЧНОСТЬ ...
Крылов, А. Ю., Петровская, А. А., Шулутко, А. М., Серебрийский, И. И., Верхоломова, Ф. Ю., Хмырова, С. Е.   +5 more
core